AXIENCE S.A.S., a company established in 2001, has carved a distinct niche in the veterinary pharmaceutical sector. Originating as a pharmaceutical operator in 2005, the company boasts a diverse product range that includes both proprietary and generic drugs tailored for a variety of animals including companion animals, equines, bovines, and porcines.
Operating out of France, AXIENCE S.A.S. has leveraged its expertise to specialize deeply in veterinary clinic hygiene and disinfection since 2003. By 2009, the company had further expanded its specialization to include anesthesia and analgesia across all animal species.
The company recently secured a Private Equity Round investment from Motion Equity Partners on 21 February 2024. This influx of capital underscores investor confidence in AXIENCE's strategic vision and its potential for sustained growth within the Health Care, Manufacturing, and Pharmaceutical industries.